I'm looking at using group sequential design for a study that will treat subjects with drug or placebo and then follow them for a year. The subjects get measured every 3 months for the year under study. They may become a "responder" at month 3, 6, 9, or 12, but they are not officially a "non-responder" until they have failed to respond for all 12 months.
My question is, group sequential designs dictate conducting interim analysis at certain milestones of % information gathered. In this scenario, I am trying to figure out how to calculate the amount of information gathered. Let's say I need 100 subjects for the power I want, and the design states IAs at 33% and 67% of information. I don't think I need to wait for 33 subjects to be studied for 12 months because some of them may be responders before 12 months. I am thinking a subject would count if they have either failed (not responded in 12 months) or responded (regardless of how long it takes them to respond).
Does that sound right? I am looking for a check on my logic since this design is new to me.